M. Du

发表

Retro-inversion follicle-stimulating hormone peptide-modified nanoparticles for delivery of PDK2 shRNA against chemoresistant ovarian cancer by switching glycolysis to oxidative phosphorylation

Xiaoyan Zhang, Congjian Xu, Meng Zhang, 2022, Cancer Nanotechnology.

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer

Xiaoyan Zhang, Cong-Jian Xu, Q. Cai, 2021, Translational cancer research.

Native T1-mapping and diffusion-weighted imaging (DWI) can be used to identify lung cancer pathological types and their correlation with Ki-67 expression

Renjun Huang, Yonggang Li, Zongqiong Sun, 2021, Journal of thoracic disease.

Ploidy Status of Ovarian Cancer Cell Lines and Their Association with Gene Expression Profiles

Xiaoyan Zhang, Congjian Xu, Xiaoxia Liu, 2023, Biomolecules.

Eukaryotic Elongation Factor 2 (eEF2) is a Potential Biomarker of Prostate Cancer

Jianquan Hou, Xue-dong Wei, Xuefeng Zhang, 2018, Pathology & Oncology Research.

Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer

Xiaoyan Zhang, Congjian Xu, Q. Cai, 2022, Experimental and therapeutic medicine.

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer

Xiaoyan Zhang, Congjian Xu, Yisheng Wang, 2022, Journal of ovarian research.

NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models

Xiaoyan Zhang, Congjian Xu, Fuyou Li, 2023, ACS applied materials & interfaces.

Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer

Q. Cai, M. Du, Mingxing Zhang, 2024, Journal of ovarian research.